Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05973331
What this trial is testing

Prospective Validation of an EHR-based Pancreatic Cancer Risk Model

Who this might be right for
Pancreatic AdenocarcinomaPredictive Cancer Model
Beth Israel Deaconess Medical Center 6,134,060
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04927780
What this trial is testing

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaResectable Pancreatic Adenocarcinoma
Erasmus Medical Center 378
Not applicableStudy completedNCT04236102
What this trial is testing

KEBI-Cyto Study - Use of the Biocartis Idylla

Who this might be right for
Pancreatic AdenocarcinomaLung Cancer
Royal Cornwall Hospitals Trust 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT04348045
What this trial is testing

Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group 307
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Large-scale testing (Phase 3)Study completedNCT01964430
What this trial is testing

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Who this might be right for
Pancreatic NeoplasmsDigestive System NeoplasmsNeoplasms by Site+7 more
Celgene 866
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07831330
What this trial is testing

Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaAlbumin-bound Paclitaxel (II)Gemcitabine+1 more
The First Affiliated Hospital with Nanjing Medical University 59
Not applicableActive Not RecruitingNCT06815172
What this trial is testing

PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

Who this might be right for
Pancreatic Adenocarcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Post-approval studies (Phase 4)Looking for participantsNCT07262957
What this trial is testing

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Who this might be right for
Pancreas Head CancerPancreas AdenocarcinomaIPMN, Pancreatic+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 400
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Not applicableStudy completedNCT02208024
What this trial is testing

Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

Who this might be right for
Pancreatic Cancer
University of Cincinnati 18
Testing effectiveness (Phase 2)Study completedNCT03340974
What this trial is testing

Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer

Who this might be right for
Pancreatic CancerStereotactic Body Radiation Therapy
Galera Therapeutics, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05624918
What this trial is testing

NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic Cancer
Ashish Manne 38
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Not applicableStudy completedNCT04400357
What this trial is testing

Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CystsPancreatic Endocrine Tumors+4 more
Ruijin Hospital 268
Early research (Phase 1)WithdrawnNCT00027521
What this trial is testing

Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ichor Medical Systems Incorporated
Early research (Phase 1)Study completedNCT01485744
What this trial is testing

LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 39
Testing effectiveness (Phase 2)UnknownNCT00275119
What this trial is testing

Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Next Page